Management Team
Stephen R. Davis
Chief Executive Officer
Serge Stankovic, M.D., M.S.P.H.
President
Austin D. Kim
Executive Vice President,
General Counsel and Secretary
Mark Schneyer
Executive Vice President, Chief Financial Officer
Brendan Teehan
Executive Vice President, Chief Operating Officer, Head of Commercial
Kathie M. Bishop, Ph.D.
Senior Vice President, Chief Scientific Officer and Head of Rare Disease
Daryl DeKarske
Senior Vice President, Global Head of Regulatory Affairs and Head of Translational Sciences
Julie Fisher
Senior Vice President, Marketing and Commercial Strategy
Bob Mischler
Senior Vice President, Strategy and Technology Operations
Ponni Subbiah, M.D., M.P.H.
Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer
Mary Ellen Turner, M.D., M.P.H.
Senior Vice President, Pharmacovigilance and Corporate Safety Officer